Cytonect launches to bring cellular science to skin care
We're introducing Cytonect — a biotechnology company developing topical therapeutics that calm inflammation at the cellular level.

Cytonect is a biotechnology company developing topical therapeutics that calm inflammation at the cellular level — beginning with a next-generation anti-inflammatory pomade for skin, with a growing pipeline of bioactive technologies.
We target the inflammatory signaling that drives irritation — addressing the cause rather than masking the surface.
Stable, tolerable, manufacturable products. Good science only matters if it becomes something you can actually use.
The pomade is the first expression of a platform. New bioactive technologies are already in development.
Our work begins with a topical anti-inflammatory pomade — and extends into a pipeline of bioactive technologies.
Calming inflammation at the cellular level.
A topical pomade engineered to reduce skin inflammation, soothe irritation, and support the skin barrier — Cytonect's lead technology.
Read the technology briefTargets the inflammatory signaling that drives irritation, rather than only masking surface symptoms.
Formulated to soothe inflamed skin while supporting its natural protective barrier.
A pomade base delivers active ingredients directly to the affected area for focused relief.
More bioactive technologies are on the way.
Cytonect is expanding its pipeline of bioactive technologies. Details for upcoming programs will be announced here.
We start at the cellular level — mapping the signaling behind inflammation and irritation.
Active ingredients are formulated into a stable topical base designed for targeted, barrier-supportive relief.
We test for stability and tolerability, refining toward a finished product ready for real-world use.
Interested in our technologies, partnerships, or what we're building next? We'd love to hear from you.